Trial Profile
Clinical outcomes of combination treatment of teriparatide and denosumab for patients with osteoporotic vertebral factures
Status:
Not yet recruiting
Phase of Trial:
Phase II
Latest Information Update: 08 Apr 2015
Price :
$35
*
At a glance
- Drugs Denosumab (Primary) ; Teriparatide
- Indications Osteoporosis; Vertebral fracture
- Focus Therapeutic Use
- 08 Apr 2015 New trial record